Atrion Update

In January, I highlighted the stock of Atrion (ATRI). I said that it’s been a spectacular performer and that no one on Wall Street follows the stock.

They describe themselves as follows:

Atrion Corporation is a leading supplier of medical devices and components to niche markets in the health care and medical industry. Atrion’s proprietary products, ranging from cardiovascular and ophthalmology products to fluid delivery devices, are sold to end-users, distributors and other manufacturers worldwide. As a developer and manufacturer of a diverse range of products, Atrion stays on the forefront of technology and manufacturing with products that meet the needs of its targeted markets.

ATRI went from $4 per share in 1989 to $459 when I wrote about it in January.

Well…it’s up another 43% since then.

Posted by on June 28th, 2017 at 3:23 pm

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.